Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 4
2007 3
2008 3
2009 2
2010 5
2011 6
2012 7
2013 3
2014 2
2015 2
2016 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Resistance to RAF inhibitors revisited.
Hartsough E, Shao Y, Aplin AE. Hartsough E, et al. J Invest Dermatol. 2014 Feb;134(2):319-325. doi: 10.1038/jid.2013.358. Epub 2013 Oct 10. J Invest Dermatol. 2014. PMID: 24108405 Free PMC article. Review.
Mechanisms of resistance to RAF inhibitors in melanoma.
Aplin AE, Kaplan FM, Shao Y. Aplin AE, et al. J Invest Dermatol. 2011 Sep;131(9):1817-20. doi: 10.1038/jid.2011.147. Epub 2011 May 19. J Invest Dermatol. 2011. PMID: 21593776 Free PMC article. Review.
Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3.
Abel EV, Basile KJ, Kugel CH 3rd, Witkiewicz AK, Le K, Amaravadi RK, Karakousis GC, Xu X, Xu W, Schuchter LM, Lee JB, Ertel A, Fortina P, Aplin AE. Abel EV, et al. J Clin Invest. 2013 May;123(5):2155-68. doi: 10.1172/JCI65780. Epub 2013 Apr 1. J Clin Invest. 2013. PMID: 23543055 Free PMC article.
The wrath of RAFs: rogue behavior of B-RAF kinase inhibitors.
Kaplan FM, Mastrangelo MJ, Aplin AE. Kaplan FM, et al. J Invest Dermatol. 2010 Nov;130(11):2669-71. doi: 10.1038/jid.2010.177. Epub 2010 Jun 24. J Invest Dermatol. 2010. PMID: 20574441 Free PMC article. No abstract available.
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page